红细胞腺苷A2B受体介导AMPK激活:促进氧输送对抗CKD的缺失环节
该研究在小鼠血管紧张素II诱导的CKD模型中筛选全血代谢物,并结合ADORA2B缺失小鼠及CKD患者,发现红细胞ADORA2B-AMPK信号通路通过促进2,3-BPG生成来增强氧输送,从而对抗肾脏缺氧和CKD进展。
要点
- 红细胞ADORA2B-AMPK信号通路激活BPG变位酶,促进2,3-BPG生成。
- 2,3-BPG增加氧输送,减轻肾脏缺氧、组织损伤和CKD进展。
- CKD患者红细胞2,3-BPG水平、AMPK活性和氧输送均升高,且与疾病严重程度成比例。
核心结论
- 小鼠和人类证据表明,ADORA2B-AMPK信号级联诱导的2,3-BPG生成促进红细胞氧输送,以对抗肾脏缺氧和CKD进展。
研究设计与样本
- 对血管紧张素II以140 ng/kg每分钟输注至多14天诱导CKD的小鼠全血代谢物进行非靶向代谢组学筛查,并与未处理小鼠比较。
- 研究缺乏红细胞ADORA2B受体的小鼠及CKD患者,以评估ADORA2B介导的氧输送在CKD中的作用。
主要发现
- 非靶向代谢组学显示,血管紧张素II诱导CKD的小鼠中2,3-BPG生成增加。
- 小鼠遗传学研究表明,红细胞ADORA2B信号通过AMPK刺激BPG变位酶激活,促进2,3-BPG生成和氧输送,以对抗血管紧张素II诱导的CKD中的肾脏缺氧、组织损伤和疾病进展。
- 增强小鼠AMPK激活可通过触发2,3-BPG生成和氧输送来抵消肾脏缺氧。
- 与对照相比,CKD患者红细胞中2,3-BPG水平、AMPK活性和氧输送更高,且变化与疾病严重程度成比例。
临床怎么用
- 这些发现为靶向该通路治疗CKD开辟了新的治疗途径。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Oxygen deprivation or hypoxia in the kidney drives CKD and contributes to end organ damage. The erythrocyte's role in delivery of oxygen (O2) is regulated by hypoxia, but the effects of CKD are unknown. METHODS: We screened all of the metabolites in the whole blood of mice infused with angiotensin II (Ang II) at 140 ng/kg per minute up to 14 days to simulate CKD and compared their metabolites with those from untreated mice. Mice lacking a receptor on their erythrocytes called ADORA2B, which increases O2 delivery, and patients with CKD were studied to assess the role of ADORA2B-mediated O2 delivery in CKD. RESULTS: Untargeted metabolomics showed increased production of 2,3-biphosphoglycerate (2,3-BPG), an erythrocyte-specific metabolite promoting O2 delivery, in mice given Ang II to induce CKD. Genetic studies in mice revealed that erythrocyte ADORA2B signaling leads to AMPK-stimulated activation of BPG mutase, promoting 2,3-BPG production and O2 delivery to counteract kidney hypoxia, tissue damage, and disease progression in Ang II-induced CKD. Enhancing AMPK activation in mice offset kidney hypoxia by triggering 2,3-BPG production and O2 delivery. Patients with CKD had higher 2,3-BPG levels, AMPK activity, and O2 delivery in their erythrocytes compared with controls. Changes were proportional to disease severity, suggesting a protective effect. CONCLUSIONS: Mouse and human evidence reveals that ADORA2B-AMPK signaling cascade-induced 2,3-BPG production promotes O2 delivery by erythrocytes to counteract kidney hypoxia and progression of CKD. These findings pave a way to novel therapeutic avenues in CKD targeting this pathway.
引用
- Peng Z, Luo R, Xie T, et al. Erythrocyte Adenosine A2B Receptor-Mediated AMPK Activation: A Missing Component Counteracting CKD by Promoting Oxygen Delivery. J Am Soc Nephrol. 2019. PMID: 31278195. doi:10.1681/ASN.2018080862
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。